Prospective Research Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$200K
- Investors
-
5
Prospective Research General Information
Description
Developer of a feed-incorporated preventative disease management technology designed for antibiotic discovery. The company's technology focuses on direct-fed microbial for aquaculture and develops adaptive microbiome modulators by using chemical communications to spur Streptomyces bacteria, enabling researchers to optimize the production of novel antibiotics.
Contact Information
Website
www.prospectiveresearch.comCorporate Office
- 376 Hale Street
- Beverly, MA 01915
- United States
Corporate Office
- 376 Hale Street
- Beverly, MA 01915
- United States
Prospective Research Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 12-Aug-2022 | $200K | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 20-Mar-2019 | Completed | Generating Revenue | |||
| 2. Seed Round | 31-Jul-2017 | $416K | $516K | Completed | Startup | |
| 1. Accelerator/Incubator | 15-Aug-2015 | $100K | $100K | Completed | Startup |
Prospective Research Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Prospective Research Patents
Prospective Research Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4384024-A1 | Methods and compositions for aquaculture | Inactive | 13-Aug-2021 | ||
| US-20250134936-A1 | Methods and compositions for aquaculture | Inactive | 13-Aug-2021 | ||
| WO-2023018691-A1 | Methods and compositions for aquaculture | Inactive | 13-Aug-2021 | ||
| US-11447742-B2 | Compositions and methods for activation and overexpression of secondary metabolites in microorganisms | Inactive | 09-Feb-2016 | ||
| US-20180346871-A1 | Compositions and methods for activation and overexpression of secondary metabolites in microorganisms | Active | 09-Feb-2016 | C12N1/38 |
Prospective Research Signals
Prospective Research Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Morningside Group | Venture Capital | Minority | ||
| Hatch Blue | Venture Capital | Minority | ||
| InnoVentures Lab | Accelerator/Incubator | Minority | ||
| SOSV | Venture Capital | Minority | ||
| RebelBio | Accelerator/Incubator | Minority |
Prospective Research FAQs
-
When was Prospective Research founded?
Prospective Research was founded in 2015.
-
Where is Prospective Research headquartered?
Prospective Research is headquartered in Beverly, MA.
-
What is the size of Prospective Research?
Prospective Research has 4 total employees.
-
What industry is Prospective Research in?
Prospective Research’s primary industry is Other Agriculture.
-
Is Prospective Research a private or public company?
Prospective Research is a Private company.
-
What is Prospective Research’s current revenue?
The current revenue for Prospective Research is .
-
How much funding has Prospective Research raised over time?
Prospective Research has raised $2.42M.
-
Who are Prospective Research’s investors?
Morningside Group, Hatch Blue, InnoVentures Lab, SOSV, and RebelBio have invested in Prospective Research.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process